angiotensin ii has been researched along with ucn 1028 c in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (58.82) | 18.2507 |
| 2000's | 12 (35.29) | 29.6817 |
| 2010's | 2 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bevan, JA; Henrion, D; Laher, I; Laporte, R | 1 |
| Schiffrin, EL; Tolloczko, B; Touyz, RM | 1 |
| Ganguly, A; Waldron, C | 1 |
| Feng, CJ; Ibrahim, IN; Kadowitz, PJ; Kaye, AD; Nossaman, BD | 1 |
| Cano, C; Malik, KU; Slavik, KJ | 1 |
| Giaid, A; Harrison, DG; Kurz, S; Münzel, T; Stewart, DJ | 1 |
| Chua, BH; Chua, CC; Diglio, CA; Siu, BB | 1 |
| Clément-Chomienne, O; Cole, WC; Walsh, MP | 1 |
| Packer, CS; Rhoades, RA; Zhao, Y | 1 |
| Balazy, M; Falck, JR; Lu, M; Reddy, KM; Wang, W; Zhu, Y | 1 |
| Naff, BP; Schwartz, DD | 1 |
| Keiser, HR; Oriji, GK | 1 |
| Gelband, CH; Neubig, RR; Posner, P; Sumners, C; Wade, SM; Zhu, M | 1 |
| Kubo, M; Quayle, JM; Standen, NB | 1 |
| Fukao, M; Hattori, Y; Kanno, M; Kitabatake, A; Sakuma, I; Sato, A | 1 |
| Hagiwara, Y; Hanada, M; Kambe, T; Kubo, T; Saito, E | 1 |
| Baur, E; Dudenhausen, JW; Fischer, T; Haller, H; Homuth, V; Horstkamp, B; Jüpner, A; Lindschau, C; Luft, FC; Neichel, D; Nissen, E; Vetter, K; Wallukat, G | 1 |
| Kadowaki, T; Seko, Y; Takahashi, N; Tobe, K; Yazaki, Y | 1 |
| Haneda, T; Kashiwagi, Y; Kawabe, J; Kikuchi, K; Nakamura, Y; Oi, S; Osaki, J | 1 |
| Chen, YL; Hung, LS; Jiang, MJ; Lee, YM; Yu, YJ | 1 |
| Hirano, K; Kanaide, H; Nishimura, J; Ushio-Fukai, M; Yamamoto, H | 1 |
| Andreis, PG; Neri, G; Nussdorfer, GG; Pelizzo, MR; Rossi, GP; Sacchetto, A; Tortorella, C | 1 |
| Davis, J; Schiebinger, R; Yingst, DR | 1 |
| Dreyfus, P; Gontero, B; Lafuma, C; Rouet-Benzineb, P | 1 |
| Fujiyama, S; Higashiyama, S; Iba, O; Iwasaka, T; Jyo, N; Koyama, Y; Maruyama, K; Masaki, H; Matsubara, H; Mori, Y; Nose, A; Nozawa, Y; Ogata, N; Tateishi, E; Tsutsumi, Y; Uchiyama, Y | 1 |
| Aiello, EA; Cingolani, HE | 1 |
| Ahn, JD; Jeon, YJ; Kaneda, Y; Lee, IK; Lee, KU; Morishita, R; Park, JY; Song, HS | 1 |
| Ichikawa, Y; Miki, T; Miura, T; Nakamura, Y; Nakano, A; Shimamoto, K; Tsuchihashi, K | 1 |
| Du, JQ; Sun, CW; Tang, JS | 1 |
| Cho, H; Ho, WK; Lee, D; Lee, SH | 1 |
| Hajjar, RJ; Mattiazzi, A; Palomeque, J; Sapia, L; Vila Petroff, M | 1 |
| Russell, ST; Tisdale, MJ; Wyke, SM | 1 |
| Sun, P; Wang, WH; Yue, P | 1 |
| England, SK; Faraci, FM; Grobe, JL; Keen, HL; Ketsawatsomkron, P; Liu, X; Lorca, RA; Pelham, CJ; Sigmund, CD; Weatherford, ET | 1 |
34 other study(ies) available for angiotensin ii and ucn 1028 c
| Article | Year |
|---|---|
Angiotensin II amplifies arterial contractile response to norepinephrine without increasing Ca++ influx: role of protein kinase C.
Topics: Alkaloids; Angiotensin II; Animals; Caffeine; Calcium; Drug Synergism; Histamine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Norepinephrine; Polycyclic Compounds; Protein Kinase C; Rabbits; Staurosporine | 1992 |
Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells.
Topics: Alkaloids; Analysis of Variance; Angiotensin II; Animals; Arginine Vasopressin; Calcium; Calcium-Transporting ATPases; Cells, Cultured; Diltiazem; Fluorescent Dyes; Fura-2; Humans; Insulin; Mesenteric Arteries; Microscopy, Fluorescence; Muscle, Smooth, Vascular; Naphthalenes; Norepinephrine; Polycyclic Compounds; Protein Kinase C; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Staurosporine; Terpenes; Thapsigargin | 1994 |
Comparative effects of a highly specific protein kinase C inhibitor, calphostin C and calmodulin inhibitors on angiotensin-stimulated aldosterone secretion.
Topics: Aldosterone; Angiotensin II; Animals; Calcium; Calmodulin; Cattle; Naphthalenes; Polycyclic Compounds; Protein Kinase C; Secretory Rate; Sulfonamides; Zona Glomerulosa | 1994 |
Influence of protein kinase C inhibitors on vasoconstrictor responses in the pulmonary vascular bed of cat and rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alkaloids; Angiotensin II; Animals; Cats; Female; Lung; Male; Naphthalenes; Norepinephrine; Polycyclic Compounds; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin; Staurosporine; Thromboxane A2; Vasoconstriction | 1995 |
Loss of adenosine-induced negative inotropic effect in hyperexcited rabbit hearts: relationship to PKC.
Topics: Acetylcholine; Adenosine; Angiotensin II; Animals; Behavior, Animal; Biphenyl Compounds; Blood Pressure; Depression, Chemical; Enzyme Activation; Heart Rate; Imidazoles; In Vitro Techniques; Losartan; Male; Myocardial Contraction; Naphthalenes; Norepinephrine; Perfusion; Phentolamine; Phorbol 12,13-Dibutyrate; Polycyclic Compounds; Propranolol; Protein Kinase C; Rabbits; Tetradecanoylphorbol Acetate; Tetrazoles | 1995 |
Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance.
Topics: Alkaloids; Angiotensin II; Animals; Aorta, Thoracic; Drug Tolerance; Endothelins; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Nitroglycerin; Phenylephrine; Phorbol 12,13-Dibutyrate; Polycyclic Compounds; Potassium Chloride; Protein Kinase C; Rabbits; Serotonin; Staurosporine; Vasoconstriction | 1995 |
Regulation of endothelin-1 mRNA by angiotensin II in rat heart endothelial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blotting, Northern; Cells, Cultured; Endothelin-1; Endothelins; Endothelium, Vascular; Gene Expression Regulation; Imidazoles; Losartan; Myocardium; Naphthalenes; Polycyclic Compounds; Protein Kinase C; Protein Precursors; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Tetrazoles | 1993 |
Angiotensin II activation of protein kinase C decreases delayed rectifier K+ current in rabbit vascular myocytes.
Topics: Alkaloids; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzophenanthridines; Biphenyl Compounds; Calcium; Enzyme Activation; Enzyme Inhibitors; Imidazoles; In Vitro Techniques; Ion Transport; Isoenzymes; Kinetics; Losartan; Membrane Potentials; Muscle, Smooth, Vascular; Naphthalenes; Phenanthridines; Portal Vein; Potassium; Protein Kinase C; Rabbits; Signal Transduction; Tetrazoles | 1996 |
Hypoxia-induced pulmonary arterial contraction appears to be dependent on myosin light chain phosphorylation.
Topics: Angiotensin II; Animals; Azepines; Enzyme Inhibitors; Hypoxia; In Vitro Techniques; Kinetics; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myosin Light Chains; Myosin-Light-Chain Kinase; Naphthalenes; Phenylephrine; Phosphorylation; Potassium Chloride; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Time Factors | 1996 |
Effect of angiotensin II on the apical K+ channel in the thick ascending limb of the rat kidney.
Topics: Angiotensin II; Animals; Cell Membrane; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Loop of Henle; Naphthalenes; NG-Nitroarginine Methyl Ester; Patch-Clamp Techniques; Penicillamine; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Sodium | 1996 |
Activation of protein kinase C by angiotensin II decreases beta 1-adrenergic receptor responsiveness in the rat heart.
Topics: Angiotensin II; Animals; Blood Pressure; Heart; Heart Rate; Male; Myocardial Contraction; Naphthalenes; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1 | 1997 |
Protein kinase C mediates angiotensin II-induced contractions and the release of endothelin and prostacyclin in rat aortic rings.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Angiotensin II; Animals; Aorta, Thoracic; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Epoprostenol; Male; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Osmolar Concentration; Peptides, Cyclic; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Staurosporine; Vasoconstrictor Agents | 1997 |
Modulation of K+ and Ca2+ currents in cultured neurons by an angiotensin II type 1a receptor peptide.
Topics: Amino Acid Sequence; Angiotensin II; Animals; Animals, Newborn; Brain Stem; Calcium; Calcium Channels; Cells, Cultured; Coculture Techniques; Egtazic Acid; Enzyme Inhibitors; GTP-Binding Proteins; Hypothalamus; Inositol 1,4,5-Trisphosphate Receptors; Kinetics; Molecular Sequence Data; Naphthalenes; Neurons; Peptide Fragments; Potassium Channels; Protein Kinase C; Protein Structure, Secondary; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Receptors, Cytoplasmic and Nuclear; Second Messenger Systems; Sodium Channels | 1997 |
Angiotensin II inhibition of ATP-sensitive K+ currents in rat arterial smooth muscle cells through protein kinase C.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Cromakalim; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Diglycerides; Enzyme Inhibitors; Glyburide; Guanosine Diphosphate; Hypoglycemic Agents; Male; Membrane Potentials; Mesenteric Arteries; Muscle, Smooth, Vascular; Naphthalenes; Patch-Clamp Techniques; Potassium; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Wistar; Staurosporine; Thionucleotides; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
A role of myofilament Ca2+ sensitivity in enhanced vascular reactivity in cardiomyopathic hamsters.
Topics: Actin Cytoskeleton; Angiotensin II; Animals; Aorta; Calcium; Calcium Channel Blockers; Cardiomyopathies; Cricetinae; Indoles; Male; Mesocricetus; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Nifedipine; Phenylephrine; Phorbol 12,13-Dibutyrate; Potassium; Ryanodine; Staurosporine; Vasoconstrictor Agents | 1998 |
Effects of genistein and staurosporine on angiotensin II-induced DNA synthesis, protein synthesis and mitogen-activated protein kinase activation in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; DNA; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Genistein; In Vitro Techniques; Male; Muscle Proteins; Muscle, Smooth, Vascular; Naphthalenes; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Staurosporine; Tetradecanoylphorbol Acetate; Vasoconstrictor Agents | 1998 |
Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.
Topics: Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoantibodies; Cells, Cultured; Female; Heart Ventricles; Humans; Immunoglobulin G; Immunoglobulin M; Molecular Sequence Data; Muscle, Smooth, Vascular; Myocardial Contraction; Naphthalenes; Peptide Fragments; Postpartum Period; Pre-Eclampsia; Pregnancy; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin | 1999 |
Pulsatile stretch activates mitogen-activated protein kinase (MAPK) family members and focal adhesion kinase (p125(FAK)) in cultured rat cardiac myocytes.
Topics: Angiotensin II; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesion Molecules; Cells, Cultured; Endothelial Growth Factors; Endothelins; Enzyme Activation; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genistein; Lymphokines; Myocardium; Naphthalenes; Phosphorylation; Protein Kinase C; Protein-Tyrosine Kinases; Rats; Signal Transduction; Stress, Mechanical; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Lovastatin prevents angiotensin II-induced cardiac hypertrophy in cultured neonatal rat heart cells.
Topics: Angiotensin II; Animals; Animals, Newborn; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cell Division; Cell Membrane; Cells, Cultured; DNA; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Myocardium; Naphthalenes; Pravastatin; Proto-Oncogene Proteins p21(ras); Rats; Rats, Sprague-Dawley; RNA; Simvastatin | 1999 |
Cyclic strain stimulates monocyte chemotactic protein-1 mRNA expression in smooth muscle cells.
Topics: Angiotensin II; Animals; Arteriosclerosis; Cell Movement; Cells, Cultured; Chemokine CCL2; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Monocytes; Muscle, Smooth, Vascular; Naphthalenes; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Rats; RNA, Messenger; Stress, Mechanical | 1999 |
The mechanism of the decrease in cytosolic Ca2+ concentrations induced by angiotensin II in the high K(+)-depolarized rabbit femoral artery.
Topics: Angiotensin II; Animals; Barium; Calcium; Calcium Radioisotopes; Calcium-Transporting ATPases; Enzyme Inhibitors; Femoral Artery; Fluorescent Dyes; Fura-2; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Naphthalenes; Potassium; Protein Kinase C; Rabbits; Thapsigargin | 2000 |
Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways.
Topics: Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Adult; Aged; Aldosterone; Angiotensin II; Endothelin-1; Endothelins; Female; Humans; Indomethacin; Isoquinolines; Male; Middle Aged; Naphthalenes; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Piperidines; Prostaglandin-Endoperoxide Synthases; Protein Kinase C; Pyrazoles; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Signal Transduction; Sulfonamides; Tumor Cells, Cultured | 2000 |
Inhibitors of tyrosine phosphatases block angiotensin II inhibition of Na(+) pump.
Topics: Angiotensin II; Animals; Arachidonic Acid; Arsenicals; Enzyme Inhibitors; Female; Naphthalenes; Phospholipases A; Phosphorylation; Protein Kinase C; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Staurosporine; Tetramisole; Tyrosine | 2000 |
Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Cell Nucleus; Cells, Cultured; DNA; Enzyme Activation; Enzyme Inhibitors; Immunohistochemistry; Matrix Metalloproteinase 9; Microscopy, Confocal; Muscles; Naphthalenes; NF-kappa B; Protein Kinase C; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Surface Plasmon Resonance; Time Factors; Transcription Factor RelA; Transcription, Genetic; Up-Regulation | 2000 |
Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Topics: Angiopoietin-1; Angiopoietin-2; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cells, Cultured; Cornea; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation; Heparin-binding EGF-like Growth Factor; Imidazoles; In Vitro Techniques; Indoles; Intercellular Signaling Peptides and Proteins; Lymphokines; Maleimides; Membrane Glycoproteins; Naphthalenes; Neovascularization, Physiologic; Olmesartan Medoxomil; Protein Kinase C; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases; Proteins; Pyridines; Quinazolines; Rabbits; Rats; Receptor Protein-Tyrosine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, TIE-2; Receptors, Angiotensin; Receptors, Cell Surface; Receptors, TIE; RNA Stability; RNA, Messenger; Tetrazoles; Time Factors; Transcriptional Activation; Tyrphostins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Angiotensin II stimulates cardiac L-type Ca(2+) current by a Ca(2+)- and protein kinase C-dependent mechanism.
Topics: Alkaloids; Angiotensin II; Animals; Benzophenanthridines; Calcium; Calcium Channels, L-Type; Cats; Egtazic Acid; Enzyme Inhibitors; Heart; In Vitro Techniques; Losartan; Membrane Potentials; Myocardium; Naphthalenes; Patch-Clamp Techniques; Phenanthridines; Protein Kinase C | 2001 |
Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells.
Topics: Angiotensin II; Cells, Cultured; Enzyme Inhibitors; Gene Expression; Genistein; Glucose; Humans; Muscle, Smooth, Vascular; Naphthalenes; Oligonucleotides; Plasminogen Activator Inhibitor 1; Protein Kinase C; Protein-Tyrosine Kinases; Transcription Factor AP-1 | 2001 |
The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning.
Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Animals; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Genistein; Glycine; Hydroxamic Acids; Immunoblotting; Ischemic Preconditioning, Myocardial; Metalloendopeptidases; Myocardial Infarction; Naphthalenes; Perfusion; Phosphorylation; Protein-Tyrosine Kinases; Rabbits; Signal Transduction; Tumor Necrosis Factor-alpha | 2004 |
Effect of angiotensin II type 1 receptor on delayed rectifier potassium current in catecholaminergic CATH.a cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Catecholamines; Cell Line; Delayed Rectifier Potassium Channels; Imidazoles; Locus Coeruleus; Losartan; Mice; Naphthalenes; Potassium Channels, Voltage-Gated; Protein Kinase C; Pyridines; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Signal Transduction; Sulfonamides; Type C Phospholipases | 2004 |
Receptor-induced depletion of phosphatidylinositol 4,5-bisphosphate inhibits inwardly rectifying K+ channels in a receptor-specific manner.
Topics: Acetylcholine; Androstadienes; Angiotensin II; Animals; Bradykinin; Dinoprost; Endothelin-1; G Protein-Coupled Inwardly-Rectifying Potassium Channels; GTP-Binding Protein alpha Subunits, Gq-G11; In Vitro Techniques; Mice; Myocytes, Cardiac; Naphthalenes; Patch-Clamp Techniques; Phenylephrine; Phosphatidylinositol 4,5-Diphosphate; Potassium Channels, Inwardly Rectifying; Wortmannin | 2005 |
Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK.
Topics: Angiotensin II; Animals; Calcium; Calcium Signaling; Depression, Chemical; Genistein; Heart Ventricles; Imidazoles; Myocardial Contraction; Myocytes, Cardiac; Naphthalenes; p38 Mitogen-Activated Protein Kinases; Protein Kinase C; Protein-Tyrosine Kinases; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species | 2006 |
Mechanism of induction of muscle protein degradation by angiotensin II.
Topics: Active Transport, Cell Nucleus; Angiotensin I; Angiotensin II; Animals; Blood Proteins; Cell Line; Enzyme Activation; I-kappa B Kinase; Luciferases; Mice; Muscle Fibers, Skeletal; Muscle Proteins; Muscle, Skeletal; Naphthalenes; NF-kappa B; Proteasome Endopeptidase Complex; Protein Kinase C; Proteoglycans; Resveratrol; Signal Transduction; Stilbenes; Transcriptional Activation | 2006 |
Angiotensin II stimulates epithelial sodium channels in the cortical collecting duct of the rat kidney.
Topics: Angiotensin II; Animals; Arachidonic Acid; Biological Transport; Enzyme Inhibitors; Epithelial Sodium Channels; Indoles; Kidney Cortex; Kidney Tubules, Collecting; Male; Maleimides; NADPH Oxidases; Naphthalenes; Protein Kinase C; Rats; Rats, Sprague-Dawley; Sodium; Superoxides | 2012 |
PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.
Topics: Angiotensin II; Animals; Blotting, Western; Female; Gene Expression Profiling; Large-Conductance Calcium-Activated Potassium Channel alpha Subunits; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Naphthalenes; Patch-Clamp Techniques; Potassium Channel Blockers; PPAR gamma; Protein Kinase C; Reverse Transcriptase Polymerase Chain Reaction; RGS Proteins; RNA Interference; Tetraethylammonium; Vasoconstriction; Vasoconstrictor Agents | 2012 |